Abstract.
Recently, it was recognized that an immune response develops along one of two major pathways. One leads to a destructive immune response (type 1), while the alternative leads to a nondestructive immune response (type 2). Our studies in animal models suggest that therapeutic vaccines induce a tumor-specific type 1 immune response while ineffective vaccines induce a type 2 response. These results have led us to examine the immune response in sentinel lymph nodes draining tumor vaccines of patients entered onto clinical trials for melanoma, breast and renal cell cancer.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chu, Y., Hu, HM., Winter, H. et al. Examining the immune response in sentinel lymph nodes of mice and men. Eur J Nucl Med 26 (Suppl 1), S50–S53 (1999). https://doi.org/10.1007/s002590050578
Issue Date:
DOI: https://doi.org/10.1007/s002590050578